United Kingdom · Question · Written question
UIN 73754
Ivermectin
Original
Introduced
12 November 2021
Last action
25 November 2021 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
25 November 2021
Summary
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential therapeutic applications of Ivermectin as a protease inhibitor.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
12 November 2021
Written question
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential therapeutic applications of Ivermectin as a protease inhibitor.
Source: Commons
25 November 2021
Answer
Protease inhibitors have an important role in the treatment of COVID-19. Therefore, the United Kingdom recently secured 250,000 patient courses of the Pfizer PAXLOVID protease inhibitor, as well as 480,000 patient courses of Merck Sharp Dohme’s polymerase...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2021-11-12/73754
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1377930
- uk · wq-1377930 · source updated 25 November 2021